There are several basic, clinical and developmental research projects in the Comprehensive Sickle Cell Center of the University of South Alabama. The existence of a core laboratory has been beneficial to these projects. The investigators proposal continued funding of the core laboratory within the USA Comprehensive Sickle Cell Center. A major objective of the laboratory is to act as the liaison between the project investigators and clinical coordinator of the Administrative Core to obtain blood and other biological samples. The investigators will also provide services which are common to several research projects, and also assist in the clinical trial of drug(s) for sickle cell subjects. Following specific aims are proposed: (1) to coordinate requests and distribution of blood samples to research investigators; (2) to provide hematological, microscopic, nutritional, biochemical and molecular data on sickle cell subjects providing blood samples; (3) to maintain a multi-user, multi-purpose, equipment room for basic and clinical investigators; (4) to provide for long-term storage of plasma and other blood products for future use; (5) to ensure compliance of research and clinical laboratories within the Center with the regulations and procedures for the use of biohazardous substances; and, (6) to assist in the clinical trial of N-cetyl cysteine for sickle cell disease by providing required hematologic, microscopic, nutritional, biochemical and/or molecular data on the subject population.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL038639-14
Application #
6450375
Study Section
Project Start
2001-04-01
Project End
2002-03-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of South Alabama
Department
Type
DUNS #
City
Mobile
State
AL
Country
United States
Zip Code
36688
Pace, B S; Qian, X; Ofori-Acquah, S F (2004) Selective inhibition of beta-globin RNA transcripts by antisense RNA molecules. Cell Mol Biol (Noisy-le-grand) 50:43-51
Haynes Jr, Johnson; Baliga, B Surendra; Obiako, Boniface et al. (2004) Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway. Blood 103:3945-50
Haynes Jr, Johnson; Obiako, Boniface (2002) Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. Am J Physiol Heart Circ Physiol 282:H122-30
Foley, Heather A; Ofori-Acquah, Solomon F; Yoshimura, Akihiko et al. (2002) Stat3 beta inhibits gamma-globin gene expression in erythroid cells. J Biol Chem 277:16211-9
Abraham, Ann; Bencsath, F Aladar; Shartava, Archil et al. (2002) Preparation of irreversibly sickled cell beta-actin from normal red blood cell beta-actin. Biochemistry 41:292-6
Kakhniashvili, D G; Goodman, S R (2001) Isolation of spectrin subunits by reverse-phase high-performance liquid chromatography. Protein Expr Purif 23:249-51
Sangerman, J; Kakhniashvili, D; Brown, A et al. (2001) Spectrin ubiquitination and oxidative stress: potential roles in blood and neurological disorders. Cell Mol Biol Lett 6:607-36
Yang, Y M; Pace, B (2001) Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms. Pediatr Pathol Mol Med 20:87-106
Dean, D A (2000) Peptide nucleic acids: versatile tools for gene therapy strategies. Adv Drug Deliv Rev 44:81-95
Xu, X S; Glazer, P M; Wang, G (2000) Activation of human gamma-globin gene expression via triplex-forming oligonucleotide (TFO)-directed mutations in the gamma-globin gene 5' flanking region. Gene 242:219-28

Showing the most recent 10 out of 54 publications